AtriCure

$66.31
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.04 (+1.59%) Today
$0.00 (0.00%) As of 11:00 PM UTC after-hours

Why Robinhood?

You can buy or sell AtriCure and other stocks, options, and ETFs commission-free!

About ATRC

AtriCure, Inc. engages development, manufacture and sale of devices designed primarily for the surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio Frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, Other International, and Total International. The company was founded by Michael D. Hooven on October 31, 2000 and is headquartered in West Chester, OH. The listed name for ATRC is AtriCure, Inc. Common Stock.

CEO
Michael H. Carrel
Employees
730
Headquarters
Mason, Ohio
Founded
2000
Market Cap
2.87B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
620.29K
High Today
$67.61
Low Today
$65.24
Open Price
$66.67
Volume
397.24K
52 Week High
$67.61
52 Week Low
$23.17

ATRC Earnings

-$0.61
-$0.44
-$0.28
-$0.11
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
-$0.28 per share
Actual
-$0.18 per share
Replay Earnings Call

You May Also Like

AAP
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure